“…Despite the fact that some studies (mainly uncontrolled or retrospective) have shown that unbalanced solutions may not be as innocent as previously thought [3−5], only recently, the SPLIT trial has shed some new light on this issue [6]. This trial (the 0.9% Saline vs. Plasma-Lyte 148 for Intensive Care Unit Fluid Therapy) is the first large randomized controlled trial comparing the clinical effects of two different types of crystalloids [6]. In this double-blind, cluster randomized, double-crossover trial, conducted in 4 ICUs in New Zealand, 2,278 ICU patients in need of crystalloid fluid therapy were enrolled to receive either 0.9% NaCl or Plasma-Lyte 148, as a balanced solution, according to an alternating block of 7-weeks for each specific ICU.…”